Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Minoryx Therapeutics, S.l.

Clinical trials sponsored by Minoryx Therapeutics, S.l., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Hope for rare brain disease: new drug trial aims to stall deadly decline Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Hope for rare brain disease: new drug trial aims to stall deadly decline

Disease control Ongoing

This Phase 3 study tests whether the drug leriglitazone can help adult men with cerebral adrenoleukodystrophy (cALD), a rare and serious brain disease. The main goal is to see if the drug delays death or the need for permanent breathing support compared to a placebo. About 40 men…

Phase 3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC